Munar Pharma

Munar Pharma ROA

Delisted

The Return on Assets (ROA) of Munar Pharma (MUN.WA) as of Nov 20, 2026 is 40.60 %. In the previous year, Return on Assets (ROA) was -390.98 % — a change of -110.38% (higher).

ROA

40.60 %

YoY

-110.38%

Last updated:

In 2024, Munar Pharma's return on assets (ROA) was 40.60 %, a -110.38% increase from the -390.98 % ROA in the previous year.

The Munar Pharma ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2017
-4.67 PLN
Jan 1, 2018
-312.40 PLN
Jan 1, 2019
0.31 PLN
Jan 1, 2020
-47.86 PLN
Jan 1, 2021
-20.91 PLN
Jan 1, 2022
-6.66 PLN
Jan 1, 2023
-390.98 PLN
Jan 1, 2024
40.60 PLN
The Munar Pharma ROA history
YEARROAYoY
40.60 %-110.38%
-390.98 %+5,770.71%
-6.66 %-68.14%
-20.91 %-56.32%
-47.86 %-15,469.11%
0.31 %-100.10%
-312.40 %+6,595.71%
-4.67 %+162.32%
-1.78 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

ROA Details

Understanding Munar Pharma's Return on Assets (ROA)

Munar Pharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Munar Pharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Munar Pharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Munar Pharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Munar Pharma stock

Return on Assets (ROA) of Munar Pharma is 40.60 % in 2024.

Return on Assets (ROA) of Munar Pharma changed from -390.98 % to 40.60 %, representing a -110.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Munar Pharma with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Munar Pharma

All Key Metrics — Munar Pharma